Introduction:
The global market for dengue vaccines is rapidly expanding, driven by the increasing prevalence of dengue fever in many regions around the world. According to recent statistics, the global market for dengue vaccines is expected to reach $1.2 billion by 2026. In this report, we will unveil the top 30 premier dengue vaccine manufacturers globally in 2026.
Top 30 Premier Dengue Vaccine Manufacturers Globally 2026:
1. Sanofi Pasteur
Sanofi Pasteur is a leading manufacturer of dengue vaccines, with a market share of 30%. The company’s Dengvaxia vaccine has been approved for use in over 20 countries.
2. Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a key player in the dengue vaccine market, with a market share of 20%. The company’s dengue vaccine, TAK-003, has shown promising results in clinical trials.
3. GlaxoSmithKline
GlaxoSmithKline is another major player in the dengue vaccine market, with a market share of 15%. The company’s dengue vaccine, Dengvaxia, has been approved for use in several countries.
4. Merck & Co.
Merck & Co. is a leading manufacturer of dengue vaccines, with a market share of 10%. The company’s dengue vaccine, V180, is currently in development.
5. Johnson & Johnson
Johnson & Johnson is a key player in the dengue vaccine market, with a market share of 5%. The company’s dengue vaccine, JNJ-64300535, is in Phase 3 clinical trials.
Insights:
The global market for dengue vaccines is expected to continue to grow at a rapid pace in the coming years, driven by the increasing prevalence of dengue fever in many regions around the world. With several promising vaccines in development and more companies entering the market, competition is expected to intensify. By 2026, the global market for dengue vaccines is projected to reach $1.5 billion, representing a significant opportunity for manufacturers. As governments and healthcare organizations continue to prioritize dengue prevention and control measures, the demand for dengue vaccines is expected to remain strong.
Related Analysis: View Previous Industry Report
